SCHEMBL24579082

SCHEMBL24579082

COCCn1cc(-c2cn3ncc(C(=O)Nc4cc(NC(=O)CN5CCC(C)(C)C5)cnc4C)c3s2)cn1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ IKBKE Q14164 7/20 0.39
▸ TBK1 Q9UHD2 7/20 0.39
▸ CHRM1 P11229 1/20 0.35
▸ PDGFRA P16234 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35
▸ BACE1 P56817 1/20 0.33
▸ WNT1 P04628 3/20 0.32
▸ GSK3B P49841 3/20 0.32
▸ DYRK1A Q13627 3/20 0.32
▸ KAT5 Q92993 1/20 0.32
▸ USP30 Q70CQ3 1/20 0.31
▸ JAK2 O60674 1/20 0.31
▸ JAK1 P23458 1/20 0.31
▸ TYK2 P29597 1/20 0.31
▸ JAK3 P52333 1/20 0.31
▸ CSF1R P07333 1/20 0.30
▸ KIT P10721 1/20 0.30
▸ WNT3A P56704 1/20 0.30
▸ IRAK4 Q9NWZ3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29760101 1.00 IKBKE (0.39) IKBKETBK1CHRM1PDGFRAHRH3
SCHEMBL24576877 0.95 IKBKE (0.40) IKBKETBK1CHRM1PDGFRAHRH3
SCHEMBL30897463 0.95 IKBKE (0.40) IKBKETBK1CHRM1PDGFRAHRH3
SCHEMBL29759772 0.94 IKBKE (0.39) IKBKETBK1CHRM1PDGFRAHRH3
SCHEMBL29760006 0.94 IKBKE (0.37) IKBKETBK1CHRM1PDGFRAHRH3
SCHEMBL24577746 0.94 IKBKE (0.37) IKBKETBK1CHRM1PDGFRAHRH3
SCHEMBL24576881 0.94 CHRM1 (0.36) IKBKETBK1CHRM1PDGFRAHRH3
SCHEMBL29759445 0.94 CHRM1 (0.36) IKBKETBK1CHRM1PDGFRAHRH3
SCHEMBL24577926 0.91 IKBKE (0.36) IKBKETBK1CHRM1PDGFRAHRH3
SCHEMBL29759615 0.91 IKBKE (0.36) IKBKETBK1CHRM1PDGFRAHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022136509-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2022-06-30 — — WO disclosed
Send feedback